Trabikibart Antibody
Trabikibart (CSL311) is a high-affinity human monoclonal antibody targeting the shared βc receptor, potently inhibiting IL-3, GM-CSF, and IL-5 signaling. It is a research tool for studying eosinophil biology and has demonstrated efficacy in preclinical models of asthma and hypereosinophilic syndromes.
Product Specifications
Product Name Alternative
CSL 311, CSL311
Target
C-Fms, IL Receptor
Clonality
Monoclonal
Conjugation
Unconjugated
Field of Research
Immunology & Inflammation, Signal Transduction
Concentration
5.51 mg/mL
Purity
95.00% (May vary between batches)
Molecular Weight
144.64 kDa
Storage Conditions
Maintain refrigerated at 2-8°C for up to 2 weeks. For long term storage store at -20°C in small aliquots to prevent freeze-thaw cycles.
Notes
For research use only.
Available Sizes
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog